£2.9M
Parkwalk led the round to help the University of Cambridge spinout expand its manufacturing and commercial reach.
S
Semarion
Semarion develops microcarrier technology that turns adherent cells into assay-ready reagents.
Cambridge, UK—Founded 2018
£2.9MTotal raised
Cambridge-based Semarion is a Cavendish Laboratory spinout that combines materials engineering with cell biology to improve drug discovery workflows.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Semarion's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
JV
Jeroen Verheyen
Jeroen is the co-founder and chief executive of Semarion. He previously held roles at Majicom, the University of Cambridge, and Cambridge Innovation Consulting.
LinkedInTV
Tarun Vemulkar
Tarun is co-founder and CTO at Semarion and previously co-founded OptiLife Innovations. His background includes research and engineering roles at the University of Pennsylvania and Micron Technology.
LinkedInRC
Russell Cowburn